Special Advertising Section
Aesynt American Health Packaging BD CutisPharma, Inc. Equashield ICU Medical, Inc. Medi-Dose/EPS Pacira Pharmaceuticals, Inc. Par Sterile Products, LLC PharMEDium Services ScriptPro Pharmacy Automation
The profiles in this section were submitted by the advertisers.
Aesynt Solving complex medication management challenges for health systems We understand that hospitals and health systems are facing complex issues. Helping solve those challenges is our top priority.
AT A GLANCE Address Aesynt 500 Cranberry Wood ds Drive Cranberry Township,, PA 16066 Phone: (800) 594-91145 Website: www.aesyn nt.com
History A customer-focused, innovative organization, Aesyntt provides hospitals and health systems with high-quality, cost-efffective and efficient solutions th hat safely deliver the right medication n closest to the patient. Founded in 1987, acquired by McKesson in 1996, an nd now owned by Francisco Partnerrs, a technologyfocused private equiity firm, Aesynt has been a leader in pharmacy automation for more e than 25 years. Enterprise Software Solutions: InsyteTM Medication Logistics Connect-Rx® Automation Decision n SupportTM IV Solutions: i.v.STATIONTM i.v.STATION ONCOTM i.v.SOFT® Central Pharmacy So olutions: ROBOT-Rx® MedCarousel® PROmanager-RxTM MedShelf-RxTM PACMEDTM PakPlus-Rx® NarcStationTM Point-of-Care Solutio ons: AcuDose-Rx® Anesthesia-RxTM
At Aesynt, our sole focus is partnering with our customers to develop long-term medication management strategies that will help them improve outcomes, build stronger businesses and manage change. As a market leader in pharmacy automation and medication management, we know the health care industry inside and out, and understand how the evolving health care landscape affects you and your business. We were the first company to offer a robotic, barcode-based solution for medication dispensing, and we now boast an integrated, flexible portfolio of solutions to address every stage of medication delivery, whether in a single hospital or across multiple facilities, regardless of medication type. It’s how we help you deliver the right medications to the right place at the right time.
Gain Control of Your Medications System-Wide Recognizing the challenges associated with managing a medication supply chain across multiple facilities, we developed and launched Insyte™ Medication Logistics, a unique solution that helps you gain control of medication inventory system-wide. Insyte provides real-time visibility and valuation for all medications to reduce waste, improve shortage management, boost productivity and minimize cost. As a result, Insyte frees pharmacy resources to contribute more to clinical care and other mission-critical efforts. Bridging the needs of pharmacy and supply chain, Insyte helps hospitals to optimize and actively manage medication inventory to support the service levels that nurses expect and patients deserve, while reducing costs and improving productivity, efficiency and inventory control. Our professional services team helps you achieve success by implementing and optimizing inventory management best practices.
Supporting the Highest-Risk, Highest-Cost Area of Pharmacy IV compounding presents the greatest risk and the greatest cost for health systems, requiring many resources and detailed preparation, yet it is the least automated area of the hospital pharmacy. As the global leader in IV automation, Aesynt offers a full complement of cost-effective solutions—including robotics, workflow and analytics—to help pharmacists more safely and efficiently produce ready-to-administer IV medications. This helps support patient and clinician safety, reduce life-threatening medication errors, increase throughput and decrease costs associated with IV compounding and dispensing. These solutions also help enhance dispensing efficiency and eliminate waste, while supporting compliance with compounding and dispensing guidelines and regulations.
20
Corporate Profiles 2014
The Most Integrated, Flexible Portfolio of Solutions Thanks to a strong working relationship with our customers, we continually reinvest in our portfolio of pharmacy automation to better address your needs. With innovative hardware and software, we’re able to bring you one of the most integrated, comprehensive and flexible portfolios of central pharmacy and point-of-care solutions available today. The benefits of automating the central pharmacy are many: substantial workflow efficiencies, better cost control, improved security, enhanced inventory management, and improved accuracy and efficiency in dispensing medications. Our goal is to reduce the pharmacy’s role in supply chain management, freeing pharmacy staff to focus on higher-value clinical care activities. Designed to optimize inventory, increase productivity, improve ease of use and reduce diversion, Aesynt’s automated point-ofcare solutions bring medications closer to clinical areas. As a result, clinicians can deliver medications to patients more efficiently and safely—on the patient floor or in the operating room—through the most integrated, comprehensive and flexible portfolio available today.
Commitment to Customer Care Customer care and success are the founding principles of our new company. We’ve invested significant resources to enhance our working relationships through Aesynt Care™, a closed-loop, multidisciplinary approach designed to help ensure that you are getting the best support from our people and the most value out of your automation investment. Every customer has a dedicated resource at every phase of our partnership. We facilitate smooth transitions from the time you purchase your automation solution through implementation, and most importantly, continue to provide the support and guidance for successful adoption and usage by your team. This helps ensure a positive return on investment for your automation solution.
Special Advertising Section Pharmacy Practice News
American Health Packaging Pharmacies juggle many critical tasks. Although patient safety is top priority, operational efficiency is important, too. Institutions seek to provide barcoded medications, while minimizing packaging tasks to enable barcode medication administration. American Health Packaging (AHP) can support you at this ”key intersection” of patient safety and operational efficiency. Our unit-dose line is the largest in the industry, with continued growth to support your needs. And we have many more items coming soon via our Pharmacy Unit Dose Plus line!
AT A GLANCE Address American Health Packaging 2550-A John Glen nn Ave. Columbus, OH 432 217 Phone: (800) 707--4621 Fax: (614) 492-04 448 Website: www.americanhealthpackaging.com
There are many benefits to AHP’s prepackaged unit-dose products: Safety. AHP is a Current Good Manufacturing Practices (cGMPs) facility, which ensures regulatory compliance. Our products are packaged in a regulated and safe environment. Our packaging professionals are adept at ensuring the product’s lot number, National Drug Code (NDC) and expiration date are recorded correctly and scan easily. Efficiency. Health systems are experts in the care of patients. Often, however, they are not as well suited or staffed for packaging tasks. Buying prepackaged unit-dose products allows staff to better focus on core competencies. Savings. Purchasing prepackaged unit-dose products often provides a cost savings to hospital pharmacies when staffing and other overhead costs are considered. Liability Management. Packaging in the hospital setting shifts the legal burden of accuracy in packaging and dispensing to hospital associates and dispensing caregivers. Prepackaged product, however, maintains a legal burden to be correct as delivered to the hospital. Exclusive Unit-Dose Items. AHP focuses on providing unit-dose items to the market where none existed in a barcoded format. In fact, our line has more than 90 exclusive items. If you’re having a difficult time finding a prepackaged unit-dose item, be sure to check with AHP!
This is a new, select line of unit-dose products. Like our core line, these items will increase safety while adding efficiency to your pharmacy operations. Unit-Dose Plus items, however, are exclusively offered in a barcoded package format by AHP. RIGHT SIZE—We know waste is an issue for you, therefore, our unit-dose products are packaged in smaller count-size cartons to avoid both waste and returns. ADDING VALUE—When all costs associated with in-house or third-party packaging are considered, Unit-Dose Plus is a lowercost alternative for obtaining barcoded ready-to-scan oral solids for your patients.
Prepackaged unit-dose products provide efficiency to your pharmacy by avoiding in-house packaging tasks.
Unit Dose Plus, a new offering of “right-sized” select, difficult-to-find unit-dose products is coming soon from AHP!
Special Advertising Section Pharmacy Practice News
Products Barcoded unit-dos se products AHP offers a full line of unit-dose products, many of which are industry exclusives.
And … Coming Soon! AHP will be broadly launching its new Pharmacy Unit-Dose Plus line of select and difficult-to-find unit-dose products later this year.
Corporate Profiles 2014
21
BD AT A GLANCE Address BD 1 Becton Drive Franklin Lakes, NJ 07417 Phone: (201) 847-6800 Website: www.bd.co om
Products Medical supplies, dev vices, laboratory instruments, antibod dies, reagents and diagnostic products
Since 1897, BD has been committed to making healthcare more effective, efficient and safer. BD is among the world’s leading suppliers of medical devices and a leading innovator in injection- and infusionbased drug delivery devices. Our focus on pharmacy builds on this legacy. Today’s pharmacy leaders must balance quality improvements and compounding legislation changes with drug shortages and budget reductions while providing quality patient care. To address these challenges, BD offers a comprehensive portfolio. Count on BD pharmacy solutions now…for healthcare’s tomorrow.
Vincent A. Forlenz za Chairman, Chief Executive Officer and President
Patient Safety
Despite best efforts, patient safety can be compromised during medication preparation and delivery. BD’s broad, innovative portfolio can help. BD Simplist™ ready-to-administer pre-filled injectables, manufactured by BD’s wholly-owned subsidiary – BD Rx and supplied in our state-of-the-art pharmaceutical plant, are designed to improve patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence1, reducing the potential risk of medication error. BD Cato™ Medication Workflow Solutions is an innovative gravimetric-based, barcode verification-enabled workflow solution that enables safe and accurate preparation of IV medications by detecting wrong drug and dose errors in real time. BD PhaSeal™ Closed System Transfer Device is designed to prevent microbial ingress, thus protecting the sterility of drug vial contents. BD Medication Preparation Products, including BD blunt fill and filter needles help to facilitate compliance with USP <797> standards, and minimize needlestick injuries due to higher skin penetration forces.
Healthcare Worker Safety OSHA reports that more workers are injured in healthcare than any other sector2. BD’s offers solutions designed to prevent occupational exposure. BD PhaSeal™ Closed System Drug Transfer Device is proven to reduce exposure to hazardous parenteral medications from pharmacy to administration3. The BD PhaSeal System is airtight and leak-proof, and mechanically prohibits the transfer of environmental contaminants into the system and the escape of drug or vapor concentrations outside the system, minimizing individual and environmental exposure. BD Disposal Solutions include collectors in a variety of colors and sizes specifically designed to safely contain sharps, non-hazardous pharmaceutical, Chemotherapy and Hazardous RCRA waste.
patient care and safety by decreasing the number of steps in the traditional vial and syringe injection sequence1, reducing the potential risk of medication error.
About BD BD is a leading medical technology company that partners with customers and stakeholders to address many of the world’s most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of “Helping all people live healthy lives” by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.
About BD Rx Inc. BD Rx Inc. is a wholly-owned subsidiary of BD (Becton, Dickinson and Company). Based on a strategic decision and long-term investment in the acute care generic injectables category BD applied its expertise in manufacturing excellence, high-quality products and service delivery to the manufacturing of high-demand generic pharmaceuticals. This is a logical extension of BD’s demonstrated 12-year history of continuous, reliable supply of our Flush platform and existing leadership position in glass prefillable syringe manufacturing and should be seen as an addition to our current pharmaceutical offerings, as it will enable us to offer a broader range of treatment options for customers. With the new BD Simplist™ ready-to-administer, prefilled injectables, BD Rx is aiming to redefine injectable drug administration practice. We envision safe patient care and efficient clinical applications and believe this is the future of injectables. For more information, please visit www.bdrxinc.com. BD and BD Simplist are trademarks of Becton, Dickinson and Company. ©2014 BD. 07/14 MSS0612 BDRx0157 1.
Workflow Efficiency and Cost Containment Today’s healthcare systems must deliver better outcomes, while still controlling costs. BD offers a portfolio that helps. BD Cato™ Medication Workflow Solutions help improve efficiency and contain cost by standardizing the medication preparation workflow, automating documentation and optimizing drug utilization to reduce drug waste. BD PhaSeal™ Closed System Drug Transfer Device is FDA ONBcleared and proven to prevent microbial ingress for up to 168 hours4 and may extend the sterile life of drugs to enable drug vial optimization. This may lead to better drug utilization, lower overall cost of operations and reduced waste5. BD Simplist™ ready-to-administer pre-filled injectables, manufactured by BD’s wholly-owned subsidiary – BD Rx and supplied in our state-of-the-art pharmaceutical plant, are designed to improve
22
Corporate Profiles 2014
Potter P, Perry A, Stockert P, Hall A. Vial & Syringe Injection Steps. Basic Nursing, 7th ed. (St. Louis, MO: Mosby, 2010) 442-447.
2. United States Department of Labor. Occupational Safety and Health Administration (OSHA). “Safety and Health Topics.” https://www.osha.gov/SLTC/healthcarefacilities/ 3. Wick et al. “Using a closed-system protective device to reduce personnel exposure to antineoplastic agents” Am J Health-Syst Pharm. 2003;60:2314-2320. 4. Edwards et al. “Cost savings realized by use of the PhaSeal closed-system transfer device for preparation of antineoplastic agents” J of Oncol Pharm Practice 2013;19(4):338-347 5. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration – 2011. Am J Health Syst Pharm. 2012;69(9):768-785.
Special Advertising Section Pharmacy Practice News
CutisPharma, Inc. CutisPharma, Inc., brings innovation and value to the prescription-compounding sector of hospital and health-system pharmacies. Patient-specific – Compounding Kits simplify the entire process by quickening preparation and helping facilitate reimbursements. What typically takes compounders up to 15 minutes to do now takes just minutes. Greater efficiencies in the compounding process bring multiple financial and clinical gains to hospital and health-system pharmacies. By using pre-measured, pre-weighed unit-of-use prescription compounding kits, pharmacies and nurses save significant staff time in preparation, help lower the total costs of compounding, and refine their just-in-time inventories to ensure ingredients are on hand when needed and ready to use over longer periods of shelf life. All dispensing containers are bar-coded for convenient bedside scanning. Clinically, the packaged reagents help deliver consistent accuracy of the compounded admixtures and speed medication delivery to patients, if compounded according to instructions, because they’re easier and quicker to use than the typical laborious processes. These benefits, in turn, may lead to better patient health outcomes. The kits also help facilitate compliance with USP <795>. “Industry-wide savings can be vast. [The] FDA estimates 30 million hospital-outpatient and retail compounding prescriptions are filled per year. Inpatient figures are also significant, yet harder to pinpoint because they lack a single NDC number,” said Jim Nagle, Vice President–Business Development at CutisPharma. The NDC number imprinted on each end-use container in every CutisPharma FIRST® – Kit facilitates third-party reimbursement for health systems. The single NDC number for the entire kit may also improve patient safety, because of minimized dispensing errors, suiting the growing number of inpatient and outpatient pharmacies that bar-code prescriptions from point of dispensing to point of care.
New Oral Solution Prescription Compounding Kits FIRST® - Vancomycin compounding kits make pharmacy compounding easier. With FIRST®– Vancomycin, the oral solution is compounded within a minute by adding the pre-measured white grape-flavored solution to the pre-weighed vancomycin hydrochloride powder bottle and shaking it. The pleasant white grape flavor helps mask the typical bitterness of vancomycin hydrochloride. These compounding kits are provided in two concentrations: 25 mg/mL (5 and 10 oz. sizes), and 50 mg/mL (5, 7 and 10 oz. sizes) for MultiFlex™ (multiple and flexible) dosing.
Compounding Kits for Widely Used PPIs CutisPharma, Inc., also offers FIRST® – Omeprazole and FIRST® – Lansoprazole Patient Specific Oral Suspension Compounding Kits. These kits will help pharmacists quickly dispense these compounded prescriptions containing widely used proton pump inhibitors (PPIs). Traditionally, compounded omeprazole and lansoprazole oral suspensions can take up to several hours to prepare and have an unpleasant taste. With FIRST® – Omeprazole and FIRST® – Lansoprazole, pharmacists need only add the liquid suspension to the powder, shake, and then within minutes can dispense to the patient with improved flavoring. “We invested a lot of time to develop these new suspension kits. The results are a pleasant-tasting strawberry-flavored medication with adequate stability once compounded,” said Dr. Indu Muni, founder,
AT A GLANCE Address
FIRST® Vancomycin Solution kits are provided in two concentrations: 25 mg/mL, 5 oz. and 10 oz sizes, and 50 mg/mL, 50 oz, 7 oz. and 10 oz. sizes.
chairman and CEO of CutisPharma, Inc. “These products offer another advantage for hospital use: Since the suspensions are made using powders and not pellets, our new compounded suspensions should flow more easily through nasogastric (NG) tubes, with minimal clogging compared to current practice. Also, our three different sizes of packaging, 3 oz., 5 oz. and 10 oz., provide considerable prescribing flexibility.”
Compounding Kits For Often-Filled ‘Magic Mouthwashes’
CutisPharma, Inc. 68 Cummings Park Woburn, MA 0180 01 Contact: Jim Nagle, Vice President– Business Developm ment Phone: (781) 935-8 8141 ext. 120 Email: JNagle@cutispharma.com Website: www.cuttispharma.com
Patient-Specific c Prescription Compounding Kits FIRST® - Vancomyc cin 25 Solution 150/mL 5, 10 oz. FIRST® - Vancomyc cin 50 Solution 150 mL 5, 7, 10 oz. FIRST® – Omeprazole Suspension: 3, 5, 10 oz. FIRST® – Lansoprazole Suspension: 3, 5, 10 oz. FIRST® – Mouthwassh BLM: 4, 8 oz. FIRST® – BXN Mou uthwash FIRST® – Duke’s Mo outhwash FIRST® – Mary’s Mo outhwash FIRST® – 10% Hydrrocortisone in Ultrasound Gel FIRST® – Progesterrone Vaginal Suppository USP: 25, 50, 100, 200, 400 mg FIRST® – Testosterone MC: 2% Testosterone in White Moisturizing Cream Base FIRST® – Testosterone: 2% Testosterone in White Petrolatum
CutisPharma, Inc., offers convenient kits that make dispensing some of the most commonly prescribed suspensions a simple, easy process. Commonly known as ‘Magic Mouthwashes,’ the products include: • FIRST® – Mouthwash BLM (Benadryl®, lidocaine and Maalox®) in two sizes • FIRST® – Mouthwash BXN (diphenhydramine, lidocaine and nystatin) • FIRST® – Duke’s Mouthwash (diphenhydramine, hydrocortisone and nystatin) • FIRST® – Mary’s Mouthwash (diphenhydramine, hydrocortisone, nystatin and tetracycline) Each FIRST® Kit has everything needed to compound one prescription from one prescriber for one patient. They include pre-weighed powders and a pre-measured suspension. The pharmacist needs only to add the powders to the liquid suspension, shake and dispense. “The company now has a wide range of FIRST® ‘Magic Mouthwash’ formulations to choose from, particularly for the most commonly prescribed and used,” Dr. Muni said. FIRST® products save dispensing time and can be compounded by the pharmacist while the patient waits, thus increasing customer satisfaction. Using FIRST® Mouthwash kits, the pharmacist can compound a prescription faster than those prepared in the conventional way.
Growing Portfolio Serves Compounding Needs The CutisPharma Kit portfolio is growing to meet pharmacy’s increasing reliance on compounding. To meet the need for efficiencies, safety and convenience, all FIRST® Patient-Specific Compounding Kits follow the simple rule of “one prescription from one prescriber for one patient.” CutisPharma, Inc., now has 24 proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, five Magic Mouthwash kits, three omeprazole suspension kits, three lansoprazole suspension kits and five vancomycin solution kits. Several more compounding kits are in the planning stages. The use of FIRST® Unit-of-Use Prescription Compounding Kits facilitates compliance with United States Pharmacopeia (USP) Chapter <797>.
FIRST® – Omeprazole and FIRST® – Lansoprazole Suspension Unit-ofUse Compounding Kits in 3, 5 and 10 oz. sizes.
Special Advertising Section Pharmacy Practice News
Corporate Profiles 2014
23
Equashield AT A GLANCE Address Equashield 99 Seaview Blvd. Port Washington, NY Y 11050 Phone: (516) 684-82 200 Website: www.equasshield.com
Hazardous drugs, such as chemotherapy drugs, and others with antineoplastic agents, present an occupational hazard to those who handle them. Occupational exposure to hazardous drugs can lead to both acute and chronic effects, ranging from skin irritation, to more serious reproductive complications and even some forms of cancer.
The CDC’s National Institute for Occupational Safety and Health (NIOSH), the US PharmacoEQUASHIELD® II - Cllosed System peia USP <797> and the recently added USP Transfer Device <800>, the American Society of Hospital For medical inquiriess related Pharmacists (ASHP) and the Oncology Nursing Equashield, contact Tammy Balzer, Society (ONS) have all recognized and made Director of Clinical S Services USA recommendations based on the potential health tammyb@equashield d.com risks associated with occupational exposure to hazardous drugs. While the dangers of hazardous drugs are often invisible to the naked eye, common practice when handling hazardous drugs creates multiple routes of exposure that can be released to and contaminate the environment despite the use of standard personal protective equipment [PPE], safety cabinets and procedures. Since hazardous drugs have adhesive characteristics, traces can often be carried out of the workspace, and are often found on unlikely surfaces like keyboards, doorknobs and other surfaces outside of the designated areas for drug compounding and delivery. NIOSH defines CSTDs as “a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system,” and the FDA recently created the ONB category that clears devices as “closed antineoplastic and hazardous drug reconstitution and transfer system.” CSTDs, which typically encapsulate the syringe and vial into one closed system, provide a vital layer of protection against hazardous drug exposure. In fact, studies have shown that using a CSTD has significantly reduced the levels of surface contamination in labs, pharmacies and hospitals.1 However, not every CSTD provides the same level of protection, and not every CSTD is equally effective at closing off the major routes of exposure. Equashield’s closed systems are among the only CSTDs in the world cleared under the FDA’s ONB code, confirming that they meet the requirements of a truly closed system. Equashield’s first and second-generation systems are also the first to be substantiated to FDA and defined in FDA cleared labeling as preventing microbial ingress up to 7 days. Equashield’s system was created with a simplified, elegant design that provides ease-of-use, and covers more routes of exposure to hazardous drugs. One of the major routes of exposure, the syringe plunger, is uniquely covered by Equashield’s system. Studies show that a typical standard syringe plunger is contaminated many times after a drug transfer when it is drawn back out. When pharmacists use standard syringes, and even when they use standard syringes that are found in other closed systems, they can be exposed to hazardous drugs due to plunger contamination, and they risk major spills, as these plastic syringes can be pulled out of the barrel completely. Equashield’s flagship CSTD, EQUASHIELD® II, introduced in late 2013, uses a metal plunger instead of a standard plastic plung-
Products
24
Corporate Profiles 2014
er. The metal rod runs through the center of the barrel, and is fully encapsulated and sealed in. This design prevents plunger contamination and it cannot be removed from the barrel, so it also prevents potential spills. The metal rod plunger cannot come in contact with the inner walls of the barrel, and therefore, remains uncontaminated by the barrel sides. In this way, Equashield’s CSTD is the only CSTD to cover this major route of exposure by minimizing plunger contamination to undetectable levels.2 Equashield developed its fully encapsulated syringe system with an internal, self-contained pressure equalizer and sterile air chamber found within the syringe barrel. This feature allows for a more streamlined design that is intuitive for those using it in the compounding, transferring and administration of hazardous drugs. Equashield’s CSTD design also innovates with its connection mechanism. Whether connecting the syringe to a vial adapter, infusion bag, or infusion tubing, each Equashield adapter and syringe are designed for safe and easy connections made in one smooth motion. Committed to protecting healthcare professionals, Equashield’s devices are qualified to the highest industry standards. Equashield’s CSTD is simple, with an elegant design and ease-of-use, which make it the CSTD of choice by hundreds of healthcare facilities in North America, Europe, Asia-Pacific, and the Middle East. Equashield is a privately held medical device company with more than 140 employees. With offices located in Port Washington, New York, and its manufacturing facilities located internationally, the company has a growing global footprint, and is committed to continuing to protect healthcare professionals from exposure to hazardous drugs.
References 1.
http://www.ncbi.nlm.nih.gov/pubmed/19965949
2. http://opp.sagepub.com/content/early/2014/03/05/1078155214526428.full. ent/early/2014/03/05/1078155214526428.full. pdf+html
Special Advertising Section Pharmacy Practice News
ICU Medical, Inc. ICU Medical helps you maximize clinician and patient safety with easy-to-use needlefree technology designed to minimize exposure to hazardous drugs and maintain drug sterility. These needlefree solutions include the world’s only needlefree closed system transfer device (CSTD) FDA 510(k) cleared for both pharmacy compounding (ONB) and patient administration (FPA) applications, as well as a CSTD with the lowest implementation cost of any other on the market.
Minimize Exposure to Hazardous Drugs While Maximizing Medication Safety Keep yourself safe from exposure to hazardous drugs and maintain drug sterility with our complete line of needlefree safehandling solutions. These convenient, needlefree CSTDs and automated drug compounding systems maintain mechanically and microbiologically closed systems to help you stay safe and in compliance with recommended guidelines during the sterile preparation of IV medications.
The Most Cost-Effective Way To Start Protecting Yourself Today With the lowest implementation cost, ICU Medical’s ChemoClave® CSTD makes the decision to start improving IV medication safety a whole lot easier. The easy-to-use ChemoClave CSTD is comprised of a selection of vial adapters that mechanically prohibit the transfer and escape of environmental contaminants, as well as a selection of needlefree bag spikes and primary add-on and administration sets. ChemoClave also generates less biohazardous waste than competing systems and helps keep you and your patients safe during every step of the hazardous drug handling process.
AT A GLANCE Address ICU Medical, Inc. 951 Calle Amanece er San Clemente, CA A 92673 Phone: (800) 824-7890 Fax: (949) 366-83 368 Website: www.icumed.com
Enhance Your Pharmacy Workflow Efficiency should not have to come at the expense of clinician and patient safety. That’s why we developed a full line of safe handling solutions that complement your workflow, not complicate it. Our needlefree CSTDs help speed preparation times by eliminating the need to assemble multiple components, and user-controlled automated compounding systems with integrated barcode scanning help increase the accuracy and speed of data entry while improving workflow traceability.
Setting a Whole New Standard for Hazardous Drug Safety With the ChemoLock™ needlefree CSTD, it has never been easier to keep yourself safe from exposure to hazardous drugs. ChemoLock’s intuitive and easy-to-use system locks with a single motion and an audible click, ensuring a safe and secure connection to minimize exposure to hazardous drugs and protect the patient preparation from contamination. ChemoLock is also the first and only needlefree CSTD to receive FDA 510(k) clearance under the ONB product code, keeping you and the drugs you mix safer while ensuring safehandling compliance.
With the lowest cost to implement of any CSTD, ChemoClave makes the decision to start improving IV medication safety easier.
Automate Your Sterile Drug Compounding Process The Diana™ hazardous drug compounding system lets you reduce the risk for exposure to hazardous drugs while maintaining drug sterility and minimizing physical stress to pharmacists and technicians. Using many of ICU Medical’s proven ChemoClave closed system components, Diana fits under the hood of your existing biologic safety cabinet to protect clinicians from exposure to hazardous drugs and accidental needlesticks.
Commitment to the Safety of Oncology Pharmacists Bringing new and innovative technologies to oncology pharmacists and technicians is at the core of who we are and what we do. We are committed to providing easy-to-use needlefree solutions that generate less biohazardous waste and lower costs while helping keep clinicians and patients safe. Only ICU Medical gives you simple, safe, and secure needlefree closed systems; CSTDs; and automated drug compounding systems to help enhance health care worker safety and comply with OSHA, NIOSH, ASHP, ISOPP, ONS, APHON and USP <797>. Contact us today to learn how we can help you improve your IV medication safe handling process by calling (800) 824-7890 or by visiting www.icumed.com. With ChemoLock, one click is all it takes to minimize exposure to hazardous drugs and maximize medication safety.
Special Advertising Section Pharmacy Practice News
Corporate Profiles 2014
25
Medi-Dose/EPS AT A GLANCE Address Medi-Dose/EPS 70 Industrial Drive Ivyland, PA 18974 Phone: (800) 523-89 966 Fax: (800) 323-8966 6 Email: info@medidos se.com Website: www.medid dose.com
For more than 40 years, the Medi-Dose System has been used by facilities of all sizes to package solid oral, unit-dose medications. With input from pharmacists and technicians, Medi-Dose has been designed to be the easiest, fastest and most cost-effective way to unit-dose and barcode your inventory.
Medi-Dose began in 1971, when Milton Braverman, a former pharmaceutical company territory manager, formed his own company. Robert Braverman, President and Director of MarketProducts ing, remembers, “My dad was acutely aware Medi-Dose® (Solid) a and of the requirements of hospital pharmacy. He ® TampAlerT (Liquid)) Oral saw the need for inexpensive, manual unit-dose Unit-Dose Packaging g packaging allowing hospitals to convert from Medi-Cup® PLUS pac ckaging for traditional dispensing. He developed systems to extended beyond-usse dating package, handle and dispense predetermined amounts of medication so they would be acces® MILT by Medi-Dose unit-dose and sible for one regular dose.” bar-coding software Although familiar today, launching the idea of LiquiDose® labeling, IV additive and unit dose was a huge problem the new company filtration products faced. “We were one of the pioneers, the innovators promoting unit-dose in hospitals,” Robert ® Nultraviolet ultravio olet light Braverman recalled. “Due in part to Medi-Dose’s inhibitant bags educational efforts, pharmacists and nurses Steri-Dropper sterile e ophthalmic accepted the validity of unit dose.” dropper bottles Inexpensive, Easy and Flexible: Because of its unique Cold-Seal technology, the Medi-Dose High Alert and IV Lin ne Tracing Labels System is simple to use and requires no special Resealable bags, botttles and other in-service training or additional space. Medi-Cup pharmacy supplies and a disposables blisters are available in a variety of sizes and styles to accommodate virtually any medication or storage system. Ultraviolet-inhibitant blisters provide additional protection from light. Plus, a combination of special blister plastics with aggressive tamper-evident label adhesives provides either six-month or one-year beyonduse dating for all your unit-dose packaging needs. • Sealed units can be left in sheets or easily torn down to individual doses. • Medi-Cup Blisters are available in five sizes to accommodate the largest medications or the smallest storage spaces. • Lid-Label Covers are available in 8 1/2˝ × 11˝ laser sheets of 25 doses or 4˝ × 6 1/4˝ direct thermal sheets of five doses.
Using our MILT 4 software, you can label and identify all your medication... complete with graphics and a bar code.
• Laser Lid-Label Cover Sheets are available in 12 colors to facilitate color-coding of medications. • New Oval Blisters and Lid-Label Covers have been designed to fit your dispensing machines and storage cabinets. • All Medi-Cup Blisters and Lid-Label Covers work with our MILT 4 software, which can be used for all your barcoding and labeling needs. Adapts to Your Needs: With our new 64 bit–compatible MILT 4 software, you can design your labels any way you want (for solids, liquids, syringes ampules, IVs—even equipment and supplies). In addition to the ability to use graphics, special fonts, tall man lettering, shapes—even logos and symbols—to better identify your medications, MILT 4 has been designed to easily create barcodes with the information that your barcode-enabled point-of-care and barcode medication administration systems require. Popular 1-D and 2-D barcode formats can be created with National Drug Code numbers, expiration dates, lot numbers and special codes.
To get started, all you will need is: 1. Medi-Cup Blisters: 13 styles to suit your packaging needs. 2. Lid-Label Covers: Laser or Direct Thermal labels to seal the blisters. 3. MILT 4 software: Design and manage Lid-Label Cover printing. 4. Fil-Form and Roll-E-ZY: Aligns Lid-Label Covers to the Medi-Cup Blisters and ensures a positive seal between labels and blisters. Inexpensive. Flexible. Tamper-Evident. If you are looking for a system to handle any or all of your unit-dose or barcoding needs, then the Medi-Dose System is a perfect fit for you!
NEW 64-bit compatible MILT4 software. Medi-Dose is simple to use and requires no special in-service training.
26
Corporate Profiles 2014
Special Advertising Section Pharmacy Practice News
Pacira Pharmaceuticals, Inc. Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products to address the needs of acute care practitioners and their patients. Pacira is driven by a dynamic workforce committed to optimizing patient care and satisfaction in the acute care setting, with a special focus on improving outcomes in postsurgical pain management.
A Proprietary Drug Delivery Platform The cornerstone of the Pacira product portfolio is DepoFoam®, a proprietary drug delivery platform designed to extend a medication’s duration of action without altering its molecular structure. The DepoFoam carrier matrix is made up of multivesicular liposomes that encapsulate a drug. Each chamber is separated by lipid membranes that naturally erode to release the drug over a desired period of time.
Clinical Utility Across a Broad Range Of Potential Applications EXPAREL has broad applications across multiple surgical specialties, as well as in the anesthesiology arena, including use as an infiltration into the transversus abdominis plane for postsurgical analgesia following abdominal procedures. In May, Pacira submitted a Supplemental New Drug Application to the FDA for a nerve block indication for EXPAREL based on positive data from a Phase III study assessing the safety and efficacy of EXPAREL in femoral nerve block for total knee arthroplasty.
The Pacira Advantage
AT A GLANCE Address Pacira Pharmaceuticals, Inc. 5 Sylvan Way Parsippany, NJ 07 7054 (973) 254-3560 www.Pacira.com For more informattion on EXPAREL, visit www.EXPARE EL.com For medical inquirries related to EXPAREL, conta act Medical Informatio on at medinfo@pacira a.com or 1-855-RX-EXPAREL (1-855-793-9727)
Discovery, innovation and proprietary expertise are the hallmarks of the Pacira competitive advantage. The company not only holds the exclusive rights and expertise to DepoFoam, but owns the unique distinction of being the only company in the world with the ability to manufacture DepoFoam-based products, such as EXPAREL, on a large commercial scale. With steadily increasing demand and a growing list of potential clinical applications, Pacira and EXPAREL are poised to become vital fixtures in the postsurgical pain management arena. For more information about Pacira Pharmaceuticals Inc., visit www. pacira.com. *Pivotal studies have demonstrated the safety and efficacy of EXPAREL in patients undergoing and bunionectomy procedures.
Important Safety Information For EXPAREL A First of Its Kind, Single-Dose Local Analgesic In 2012, Pacira successfully launched EXPAREL® (bupivacaine liposome injectable suspension), the first and only DepoFoam-based local analgesic. Indicated for administration into the surgical site to produce postsurgical analgesia, a single dose of EXPAREL provides nonopioid pain control with reduced opioid requirements for up to 72 hours* without the need for catheters or pumps.1
Shifting the Postsurgical Pain Management Paradigm The launch of EXPAREL is bolstered by a robust Phase IV clinical program, which builds a compelling case for EXPAREL as the foundation of an opioidsparing multimodal postsurgical pain management regimen. Recently published national and regional retrospective analyses2,3 of more than 350,000 postsurgical patients receiving opioids concluded that those who experienced opioid-related adverse events had both longer hospital lengths of stay and higher hospitalization costs. The company’s efforts are buoyed by a groundswell movement led by government and independent health care organizations to mitigate potentially fatal side effects related to opioid use by recommending a shift toward opioid-sparing pain regimens, especially in high-risk postsurgical patients.
EXPAREL is contraindicated in obstetrical paracervical block anesthesia. EXPAREL has not been studied for use in patients younger than 18 years of age. Non– bupivacaine-based local anesthetics, including lidocaine, may cause an immediate release of bupivacaine from EXPAREL if administered together locally. The administration of EXPAREL may follow the administration of lidocaine after a delay of 20 minutes or more. Other formulations of bupivacaine should not be administered within 96 hours after administration of EXPAREL. Monitoring of cardiovascular and neurological status, as well as vital signs should be performed during and after injection of EXPAREL as with other local anesthetic products. Because amide-type local anesthetics, such as bupivacaine, are metabolized by the liver, EXPAREL should be used cautiously in patients with hepatic disease. Patients with severe hepatic disease, because of their inability to metabolize local anewsthetics normally, are at a greater risk for developing toxic plasma concentrations. In clinical trials, the most common adverse reactions (incidence ≥10%) following EXPAREL administration were nausea, constipation, and vomiting. 1. Gorfine SR, et al. Diseases of the Colon & Rectum. 2011;54(12):1552-1559. 2. Oderda GM, et al. Journal of Pain & Palliative Care Pharmacotherapy. 2013;27(1):62-70. 3. Kessler ER, et al. Pharmacotherapy. 2013;33(4):383-391.
PP-EX-US-0185
Special Advertising Section Pharmacy Practice News
Corporate Profiles 2014
27
Par Sterile Products, LLC “Providing patients and customers with uncompromising quality and value.” Quality You Can Depend On
AT A GLANCE
The legacy of Par Sterile Products reaches
back to the birth of the American pharmaceutical industry at the turn of the 20th Address century. With a sterile manuPar Sterile Products,, LLC facturing facility located in n Morris Corporate Center 2 Rochester, Mich., Par Steri le One Upper Pond Rd., Building D, Products possesses an 3rd Floor Parsippany, NJ 0705 54 unparalleled reputation for high-quality prodCustomer Service ucts and an impeccable (877) 547-4547 record of regulatory compliance. Our iconic Drug Safety/Medic cal Information brands, such as Aplisol® (800) 828-9393 Opttion 3 and Adrenalin®, have been relied on by physiChief Executive Officer cians and patients for Paul Campanelli decades. While proud of our heritage, we are even prouder of the great things we are accomplishing today. In an injectables world frequently plagued by compliance issues and product shortages, Par Sterile Products stands as a highly regarded partner with exemplary trade service levels and an impeccable record of regulatory compliance. Every week in America, more than 1 million Par prescriptions are dispensed, including Par Sterile Products. In return for the trust that is placed in us, we are committed to providing products of uncompromising quality. In fulfilling this mission, we deliver value to our customers and the physicians and patients who rely on us.
and distributing safe, innovative and cost-effective branded and generic aseptic injectable pharmaceuticals that help improve patient quality of life. We also provide contract manufacturing services to our partners in the biopharmaceutical and pharmaceutical industry. Today, our company’s sales, together with Par Pharmaceutical, Inc., and its other subsidiaries, place it among the top five largest generic pharmaceutical companies in the United States. At A Par Sterile Products, our most important resource iss the talent and dedication of our nearly 500 employee es, each of whom is part of a culture that values integrity, customer focus, teamwork v and performance.
Promising Product Pipeline Par Sterile Products currently markets a portfolio of 14 specialty injectable products, including Brevital®, Dantrium®, Pitocin® and zoledronic acid. Since 2012, Par Sterile Products has launched nine new S products. We possess one of the most promising new product pipelines in the injectable space, having developed a pipeline currently consisting of 34 products, 17 of which have already been submitted for FDA approval. We expect at least a half-dozen more ANDA filings before year end, fueled by our commitment to investment in research and development. At Par Sterile Products, we are large enough to maintain a significant trade presence, yet agile enough to provide maximum attention to our customers, and we remain poised to continue our impressive track record of success. For more information, please visit www.parpharm.com.
PAR—People Achieving Results!
Partners for Health Care Excellence Par Sterile Products, LLC, a subsidiary of Par Pharmaceutical, Inc., is at the forefront of developing, manufacturing, marketing
28
Corporate Profiles 2014
Special Advertising Section Pharmacy Practice News
PharMEDium® Services At PharMEDium, we are committed to patient safety. We take extraordinary measures to ensure the safety and sterility of our services. Count on PharMEDium to provide sterile preparations with the highest levels of quality assurance and patient safety in mind. From the use of FDA-approved sterile components to proven leadership in R&D, quality, labeling/packaging and service, you can expect customized admixtures of the highest quality. As the leader in the admixture business for more than a decade, our company has been an advocate for you and your patients. PharMEDium was one of the first entities to register voluntarily with the FDA as a Human Drug Compounding Outsourcing Facility under
Section 503B of the Federal Food, Drug, and Cosmetic Act. PharMEDium provides sterile compounded preparations to hospital pharmacies as an extension of their sterile preparation for IV and epiAddress dural therapy requirements, using FDA-approved PharMEDium Serv vices sterile drugs and sterile containers. PharMEDium Two Conway Park helps meet the demands placed on hospitals to 150 North Field Drrive ensure that patients receive their medications on Suite 350 time and as prescribed. Lake Forest, IL 60 0045 It is our mission to be the preeminent provider Phone: (800) 523--7749 of choice for hospital customers and to attain Website: www.pha armedium.com the highest degree of integrity in the compounding of sterile preparations. Services Labeling: Our complete and total commitment Delivering only the highest quality, to advancing patient safety is embodied through ready-to-use comp pounded sterile first-in-class labeling, packaging and cuttingpreparations for use within the edge barcode scanning technology designed to medical triad of ca are. help reduce the potential for medication errors. Service: As a PharMEDium customer, you Pain managementt PCAs and epidurals; labor an nd delivery; not only deserve the highest level of quality, nerve block and lo ocal anesthetics; you deserve the highest level of service. That’s OR anesthesia syrringe preparations; why we assign a team of professionals to each ICU services. customer. Your team will supply what you need, from the emergency department to the operating room to the patient’s room. Electronic 222 (CSOS) ordering at pharmedium.com makes ordering easy, convenient and reliable. Additionally, online order status and invoice preview mean you can get your questions answered with a few simple clicks of the mouse.
AT A GLANCE
®
Special Advertising Section Pharmacy Practice News
Corporate Profiles 2014
29
ScriptPro Pharmacy Automation AT A GLANCE Address ScriptPro Pharmacy Automation 5828 Reeds Road Mission, KS 66202 Phone: (913) 384-100 08 Websites: www.scrip ptpro.com, www.scriptproblog.c com
President and CEO O Michael E. Coughlin
Major Products SP Central Pharmacy y Management System SP 200/SP 100/SP 5 50 Robotic Prescription Dispenssing Systems CRS/CRS 150/CRS 225 Compact Robotic Systems SP Central Workflow w System SP Central Telepharm macy for Sterile Room Med Prep
ScriptPro offers a comprehensive line of more than 150 pharmacy automation and management system products that have revolutionized pharmacy operations in the United States, Canada and many other countries. The company’s initial product, the SP 200 Robotic Prescription Dispensing System, pioneered the use of robotics in community pharmacies. ScriptPro has grown through invention and product development, instead of acquisition. It owns the core technologies utilized, and manufactures, sells, installs and supports all of its products. Safety and accuracy are the hallmarks of ScriptPro’s line of integrated pharmacy systems—helping today’s pharmacies achieve better patient outcomes. ScriptPro world headquarters in Mission, Kansas.
SP Central Pharmacy Management System Achieve better patient outcomes with ScriptPro’s Perfect Integration. Your pharmacy staff will provide consistent prescription information across all systems, enable patient access to pharmacy services and dramatically improve compliance.
Highlights: • Accept e-prescriptions without keying or scanning any prescription data. • E-fax prescribers for refill requests and prior authorizations. • Manage multiple inventories, allowing you to place orders and track pricing separately. SP Central Pharmacy Management System includes our powerful SP Central Workflow.
SP Central Workflow System
ScriptPro SP 200 Robotic Prescription Dispensing System
Robotic Prescription Dispensing Systems
With ScriptPro’s SP Central Workflow System, you know the “who, what, when, where and why” of every prescription that you process. Enforced barcode scanning ensures dispensing accuracy.
No two pharmacies are alike and that’s why ScriptPro has designed six robot configurations, starting at just 7 sq ft.
Highlights:
Highlights: • Track 100% of the prescriptions in your pharmacy, whether robotically or manually filled. • Batch all prescriptions by patient so everything stays together. • Retrieve images of hard copy prescriptions at any step of the prescription filling process—useful for customer verification or third-party audit.
• The right-sized robot for your specific pharmacy, it fits against a wall to maximize tight spaces. • Best industry service: all-inclusive 24/7/365, guaranteed support for 10 or more years, single-vendor solution.
ScriptPro Robot Statistics
30
Corporate Profiles 2014
Special Advertising Section Pharmacy Practice News